XG 102

Create: 12/10/2018

Expired Date:	never
Category:	Health&Medical&Pharmaceutical
Message:	XG-102, a TAT-coupled dextrogyre peptide inhibiting the c-Jun N-terminal kinase, was shown efficient in the treatment of experimental uveitis. Research show that XG-102 peptide has potential for treating intraocular inflammation.https://www.creative-peptides.com/product/xg-item-10-101-141-34910.html






City:	Shirley[US]
Location:

Aug 09 2019	HLA-A_24_02 CMV pp65 tetramer-QYDPVAALF-PE labeled	532
Aug 09 2019	H-2Db LCMV gp33 tetramer-KAVYNFATC-APC labeled	550
Aug 09 2019	H-2Kb TRP-2 tetramer-SVYDFFVWL-PE labeled	521
Aug 09 2019	H-2Db WT1 tetramer-RMFPNAPYL-PE labeled	443
Aug 09 2019	H-2Kb HBV core tetramer-MGLKFRQL-APC labeled	529
Aug 09 2019	T-Select H-2Kb Negative (SIY) tetramer-SIYRYYGL-PE labeled	503
Aug 09 2019	T-Select H-2Kb MuLV p15E tetramer-KSPWFTTL-PE labeled	533
Aug 09 2019	T-Select H-2Kb OVA tetramer-SIINFEKL-APC labeled	559
Aug 09 2019	T-Select HLA-A_24_02 survivin-2B tetramer-AYACNTSTL-APC labeled	514
Aug 09 2019	T-Select HLA-A_02_01 CMV pp65 tetramer-NLVPMVATV-PE labeled	534